Ribomic Inc. provided non-consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects operating revenues of JPY 65 million, operating loss of JPY 2,402 million, loss of JPY 2,294 million or JPY 80.35 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84 JPY | 0.00% | 0.00% | -22.22% |
1st Jan change | Capi. | |
---|---|---|
-22.22% | 19.46M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- 4591 Stock
- News Ribomic Inc.
- Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023